METHOD FOR THE ANALYSIS OF OVARIAN CANCER DISORDERS
    12.
    发明申请
    METHOD FOR THE ANALYSIS OF OVARIAN CANCER DISORDERS 失效
    OVARIAN癌症分析方法

    公开(公告)号:US20100273674A1

    公开(公告)日:2010-10-28

    申请号:US12678423

    申请日:2008-09-16

    IPC分类号: C40B30/04 C12Q1/68 C40B40/06

    摘要: The invention relates to a method for the analysis of ovarian cancer disorders, comprising determining the genomic methylation status of one or more CpG dinucleotides in a sequence selected from the group of sequences according to SEQ ID NO. 1 to 10 and/or SEQ ID NO. 50 to SEQ ID NO. 60. Optionally, additionally following steps are performed, the one or more results from the methylation status test is input into a classifier that is obtained from a Diagnostic Multi Variate Model, calculating a likelihood as to whether the sample is from a normal tissue or an ovarian cancer tissue and/or, calculating an associated p-value for the confidence in the prediction.

    摘要翻译: 本发明涉及一种用于分析卵巢癌病症的方法,包括确定一种或多种CpG二核苷酸的基因组甲基化状态,所述序列选自SEQ ID NO。 1至10和/或SEQ ID NO。 50至SEQ ID NO。 可选地,另外执行以下步骤,将来自甲基化状态测试的一个或多个结果输入到从诊断多变量模型获得的分类器中,计算样品是来自正常组织或 卵巢癌组织和/或计算预测中置信度的相关p值。

    Method for the analysis of ovarian cancer disorders
    14.
    发明授权
    Method for the analysis of ovarian cancer disorders 失效
    卵巢癌症分析方法

    公开(公告)号:US08652777B2

    公开(公告)日:2014-02-18

    申请号:US12678423

    申请日:2008-09-16

    IPC分类号: C12Q1/68 C12P19/34

    摘要: The invention relates to a method for the analysis of ovarian cancer disorders, comprising determining the genomic methylation status of one or more CpG dinucleotides in a sequence selected from the group of sequences according to SEQ ID NO. 1 to 10 and/or SEQ ID NO. 50 to SEQ ID NO. 60. Optionally, additionally following steps are performed, the one or more results from the methylation status test is input into a classifier that is obtained from a Diagnostic Multi Variate Model, calculating a likelihood as to whether the sample is from a normal tissue or an ovarian cancer tissue and/or, calculating an associated p-value for the confidence in the prediction.

    摘要翻译: 本发明涉及一种用于分析卵巢癌病症的方法,包括确定一种或多种CpG二核苷酸的基因组甲基化状态,所述序列选自SEQ ID NO。 1至10和/或SEQ ID NO。 50至SEQ ID NO。 可选地,另外执行以下步骤,将来自甲基化状态测试的一个或多个结果输入到从诊断多变量模型获得的分类器中,计算样品是来自正常组织或 卵巢癌组织和/或计算预测中置信度的相关p值。